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Background: The gastrointestinal peptide hormones cholecystokinin and gastrin exert their biological functions via
cholecystokinin receptors CCK1R and CCK2R respectively. Gastrin, a central regulator of gastric acid secretion, is
involved in growth and differentiation of gastric and colonic mucosa, and there is evidence that it is pro-carcinogenic.
Cholecystokinin is implicated in digestion, appetite control and body weight regulation, and may play a role in several
digestive disorders.
Results: We performed a detailed analysis of the literature reporting experimental evidence on signaling pathways
triggered by CCK1R and CCK2R, in order to create a comprehensive map of gastrin and cholecystokinin-mediated
intracellular signaling cascades. The resulting signaling map captures 413 reactions involving 530 molecular species,
and incorporates the currently available knowledge into one integrated signaling network. The decomposition of the
signaling map into sub-networks revealed 18 modules that represent higher-level structures of the signaling map.
These modules allow a more compact mapping of intracellular signaling reactions to known cell behavioral outcomes
such as proliferation, migration and apoptosis. The integration of large-scale protein-protein interaction data to this
literature-based signaling map in combination with topological analyses allowed us to identify 70 proteins able to
increase the compactness of the map. These proteins represent experimentally testable hypotheses for gaining new
knowledge on gastrin- and cholecystokinin receptor signaling. The CCKR map is freely available both in a downloadable,
machine-readable SBML-compatible format and as a web resource through PAYAO (http://sblab.celldesigner.org:18080/
Payao11/bin/).
Conclusion: We have demonstrated how a literature-based CCKR signaling map together with its protein interaction
extensions can be analyzed to generate new hypotheses on molecular mechanisms involved in gastrin- and
cholecystokinin-mediated regulation of cellular processes.
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Gastrin and cholecystokinin (CCK) are gastrointestinal
peptide hormones that share a common C-terminal pen-
tapeptide amide [1]. Gastrin, produced in G-cells of the
gastric antrum, is the central regulator of gastric acid se-
cretion but also regulates growth and differentiation of
gastric and colonic mucosa [2]. CCK, produced primarily
in I-cells of the small intestine, is involved in physio-
logical processes such as digestion, appetite control and
body weight regulation [3]. The scientific interest in
these hormones is further strengthened by their roles in
several diseases. Indeed, CCK has been implicated in
acute pancreatitis [4–6], obesity [7, 8], irritable bowel
syndrome [9] and gall bladder disease [10, 11]. Gastrin is
known to be pro-carcinogenic, affecting proliferation,
angiogenesis and apoptosis [2], and is a risk co-factor for
gastric carcinogenesis and atrophy upon Helicobacter
pylori infection [12, 13]. In order to efficiently study and
understand the molecular mechanisms triggered by gas-
trin and cholecystokinin, detailed knowledge concerning
the signaling pathways they regulate is paramount.
Information concerning intracellular signaling is com-
monly retrieved from databases such as Reactome [14]
and KEGG [15]. However, none of these resources cur-
rently specify which specific molecular events are known
to take place in response to gastrin or CCK. Researchers
in need of such knowledge therefore must spend signifi-
cant time reviewing current literature in order to gain
an exhaustive and up-to-date understanding of the sig-
naling network. A comprehensive map of gastrin and
CCK intracellular signaling pathways would significantly
assist in the study of normal or aberrant cholecystokinin
receptor (CCKR) signaling.
In the past decade, several manually constructed maps
of signaling events have been published [16–25], each
providing solid foundations for a systems understanding
of the signaling mechanisms. The present work extends
this approach to the domain of CCKR signaling by pro-
viding a comprehensive literature-based CCKR signaling
map that comprises 530 molecular species and 431 reac-
tions, considerably extending previously compiled know-
ledge on CCK2R signaling [10, 26] including CCK1R
downstream events.
Partitioning the total CCKR signaling map into sub-
networks using the BiNoM tool [27] resulted in 18 mod-
ules that coordinate with each other to elicit the diverse
intracellular signaling responses to gastrin and/or CCK.
Finally, we used the CCKR map as a scaffold for protein-
protein interaction (PPI) data integration assisted by
PathExpand [28], in order to predict novel components
of the signaling network. This resulted in the identifica-
tion of 70 new proteins tightly connected to the CCKR
signaling map, making them prime candidates for fu-
ture experimental work aimed at further extendingknowledge on regulation of CCKR mediated signaling
mechanisms.
Methods
Construction of the CCKR map from literature
The CCKR map was constructed using CellDesigner 4.2,
a structured diagram editor for drawing gene-regulatory
and biochemical networks, following the Systems Biol-
ogy Graphical Notation (SBGN) standard for process di-
agrams [29] and the Systems Biology Mark-up Language
(SBML) for model representation [30]. The MIRIAM
(Minimum Information Requested In the Annotation of
Models) guidelines were followed to characterize each
species in the map [31].
i). Knowledge encoded in the CCKR map was obtained
from scientific publications that were identified by
searching for different combinations of cholecystokinin
(CCK)/CCK1R and gastrin (G-17)/CCK2R in PubMed
or through various literature mining tools, e.g.
LitInspector (http://www.genomatix.de/solutions/
genomatix-software-suite.html) [32] and iHOP (http://
www.ihop-net.org/UniPub/iHOP/) [33]. We adopted
two main criteria as guidelines for including a
scientific paper for the information extraction, namely
that it must contain:
1) evidence that the reported signaling event is
mediated by the specific interaction of CCK or
gastrin (G-17) with their receptors CCK1R and
CCK2R.
2) signaling information to allow for linkage of a
new CCKR map component to its upstream
and/or downstream regulators in CCKR
signaling.
ii). CellDesigner species and reaction “note” features
were used to record PubMed IDs (PMID), cell-type
specific information for each reaction, and the
interacting components in the CCKR map.
iii).Final curation and quality control was done in a
collaborative effort involving five different research
group members who collectively used the community
curation platform PAYAO (http://www.payaologue.
org) [34], enabling efficient exchange of comments
and tags. Consensus and critical comments from each
annotator about the precise representation of
reactions, components, and their cellular localization
were discussed and implemented (Fig. 1). Finally, the
CCKR map was published with an open source license
for the whole scientific community through PAYAO
[34] (map available at: http://sblab.celldesigner.org:
18080/Payao11/bin/). The CCKR map is also available
in the SBML data exchange format (Additional file 1),
and we are also in the process of submitting this map
to the PANTHER database [35].
Fig. 1 CCKR map collaborative curation in Payao. Shows detail from CCKR map in Payao web tool illustrating collaborative efforts involving five
CCKR map curators. Evaluation- and action points for reactions, components and cellular localizations are indicated with the Tagsets ‘OK’ (green),
‘DISCUSSION’ (yellow), ‘INCORRECT’ (red) and ‘IMPLEMENTED’ (blue)
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of curators to continue increasing the quality of this
CCKR signaling map and will keep it up to date with
our growing biological understanding.
Analysis of the CCKR map
Network topology studies were performed by importing
the CellDesigner-generated SBML file of the CCKR map to
Cytoscape version 2.8 [36] using the BiNoM plugin [27],
after removing connections downstream of the transcrip-
tion factor layer. BiNoM considers both ‘reaction’ and
‘species’ of a CellDesigner map as a node. The Cytoscape
version of the CCKR map consisted of 807 nodes (475 spe-
cies and 332 reactions) with 963 edges. Node degree and
closeness centrality were calculated using the ‘Network
Analysis’ plugin [37] in Cytoscape, assuming the network
to be undirected. The number of nodes connected directly
to a particular node defines its node degree k, and the node
degrees of all nodes in the network represent the ‘degree
distribution’ of the network. Nodes with degree k > 5 were
termed ‘hubs’.
BiNoM decomposition of CCKR map into modules
We used the ‘prune the graph’ function of BiNoM to auto-
matically separate the strongly connected component
(SCC), i.e. the central cyclic motif of the map, from more
loosely connected upstream and downstream species. The
SCC was further decomposed into smallest sub-networkswith the function ‘extract material components’. Next, some
manual curation work was performed: sub-networks with
50 % or more overlapping nodes were clustered together
while the large sub-networks were decomposed further until
each sub-network contained a unique central cyclic motif.
Any unconnected nodes were removed from the sub-
networks, yielding a total of 18 sub-networks or modules.
Next, these 18 modules were merged together and the re-
sulting network was compared with the initial map to check
for completeness in terms of any missing interactions or
nodes. The complete map and its 18 decomposed modules
are available as a Cytoscape session file (Additional file 2).
Protein-protein interaction based expansion of the CCKR
map
PPI data were downloaded using PSICQUIC (all data-
bases, version June 2012), and filtered for binary physical
interactions based on PSI-MI controlled vocabulary ex-
perimental method descriptions, following the procedure
in [38] (Charles E. Chapple, personal communication).
We then tested each of the 4119 proteins found to inter-
act with CCKR signaling map proteins with the PathEx-
pand method [28] to seek for tightly linked protein
interactors that enhance the network compactness of the
CCKR map by leading to higher node degree, between-
ness and average local clustering as well as decreasing
the shortest path lengths (for details see [28]) .
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CCK and gastrin impinge on cellular functioning by
binding to two different G protein-coupled receptors,
CCK1R and CCK2R, respectively, located at the surface
of multiple cell types in peripheral organs such as the
gastrointestinal tract, the pancreas, and the gall bladder
[39]. Today, no comprehensive resource exists that com-
piles current knowledge on CCKR activated signaling
pathways. Gastrin has a strong preference for CCK2R,
while CCK can activate both receptors with similar affin-
ities [10]. Most cell types responsive to one or both pep-
tide hormones express only one CCK-receptor variant.
However, a range of normal and cancer cells in whole
organisms as well as model cell lines (for instance the
rat pancreatic acinar cell derived cell-line AR42J [40])
express both CCK1R and CCK2R.
The CCKR signaling map
We present a CCKR signaling map built with biological
inferences from more than 250 scientific publications
(including original articles and reviews), and based on
experiments performed in 37 different cell lines repre-
senting a wide array of cell types (Fig. 2, Methods).
The CCKR map encompasses 199 unique proteins and
their relationships to complexes, genes, and small mole-
cules (including some inhibitors, e.g. rapamycin, wort-
mannin), describing a total of 530 molecular species and
431 reactions experimentally documented to play a role
in CCKR signaling. The reactions include molecular
state transitions (e.g. activation, phosphorylation), trans-
port, heterodimer associations/dissociations as well as
transcriptional regulation of target genes by transcrip-
tion factors, which are reported to be associated with
the regulation of gastrointestinal hormone responsive
biological processes (Table 1).
Figure 2a displays a detailed view of the map depicting
the two ligands gastrin and CCK, their biogenesis and
processing, their binding to the two G protein coupled
receptors CCK1R and CCK2R and the ensuing signal
transduction pathways including activation of transcrip-
tion factors and downstream target genes reported to be
triggered in response to gastrin and/or CCK. Moreover,
a number of cellular processes influenced by specific
CCKR signaling events are indicated, including prolifera-
tion, migration, differentiation, anti-apoptosis and in-
flammation. Figure 2b is an aid for the reader to
navigate in Fig. 2a, as it indicates the position of major
pathways involved, including protein kinase C (PKC)-
dependent activation of MAPK cascades, PI3K-mTOR
signaling, protein kinase A (PKA)-dependent pathway,
β-catenin, and Rho-GTPase-Bcl cascades.
Network topology analysis of the CCKR map indicated
scale-free characteristics, with the majority of the pro-
teins connected to only few other network proteins(Fig. 3). The 6 most highly connected proteins include
four protein kinases AKT1, SRC, PKC and PAK1, and
the small GTPase HRAS (Fig. 3, inserted table).
Signaling pathways shared by CCK1R and CCK2R
Downstream signaling mechanisms shared by CCK1R
and CCK2R include the trimeric guanine nucleotide
binding alpha q protein (G-protein αq), PKC dependent
phosphorylation of adaptor protein SHC - transforming
protein C, and its association with GRB2/SOS1 leading
to activation of the HRAS/RAF/MAPK1/3 cascade [10, 41,
42]. Other shared pathways involve MAP3K11-mediated
regulation of MAPK8, −9 and −10 and p38MAPK
(MAPK14), PRKD1 (in PKC signaling), PI3K, AKT1,
FAK1, JAK2-STAT3 and Rho GTPase [10, 41–44]. Both
receptors activate PKC isoforms PKCα, −δ, −ε, −θ and −ζ
[10, 45–47]. Transcription factors reported downstream of
both CCK1R and CCK2R receptors include NFκB, CREB1,
ELK1 and AP1.
CCK1R-specific signaling pathways
Two trimeric G-proteins appear to be regulated only by
CCK1R. One is G alpha S (Gαs) [48], which leads to Pro-
tein kinase A activation via adenylate cyclase catalyzed
cAMP production, and the other is G alpha 13 (Gα13)
[43], involved in downstream activation of RHOA [49].
The NOS1 signal transduction pathway downstream of
CCK1R [50, 51] regulates Ca2+ signaling pathways by
opening ryanodine receptors and two-pore channels that
release calcium from the endoplasmic reticulum and
endolysosomes, respectively [52–54]. Other signaling cas-
cades, so far only reported for CCK1R, include the Ca2
+/calmodulin (CaM) dependent activation of CaMKIV and
calcineurin (CaN) – NFAT1 signaling pathways [55–57].
CCK2R-specific signaling pathways
CCK2R activates EGFR via PKC activated MMP3, which
cleaves membrane-attached pro-HBEGF into mature
HBEGF [58, 59]. PKC isoforms PKC-β and PKC-η have
been reported only downstream of CCK2R signaling [60,
61]. CCKR2 specific activation of β-catenin and E-
cadherin is mediated by PAK1 [62, 63], and CCK2R spe-
cific modulation of BCL-protein family signaling regulates
mitochondrial cytochrome C release [64, 65]. CCK2R, but
not CCK1R, is reported to activate MAPK7 [66], an up-
stream regulator of transcription factors MEF-B,-C and D,
and the PKC-η target PRKD2 [60], which enhances nu-
clear export of HDAC7 thereby relieving transcriptional
repression of target genes such as NR4A1 [67].
Segmentation of the CCKR signaling map into modules
The complete CCKR signaling map (Fig. 2) is very large.
We therefore set out to identify structural and functional
subdomains of this map. We used the BiNoM software
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Fig. 2 CCKR map (CellDesignerTM 4.2). a Literature curated comprehensive map of the CCK1R, CCK2R mediated signaling pathways comprising
530 species and 431 reactions (see Table 1 for further details). The graphical representation is also available as an SBML file (Additional file 1)
b Navigation map to track components and signaling cascades in the detailed map shown in part A
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Table 1 Overview of the CCKR map
Species Reactions
Category Number (530) Category Number (431)
Proteins 314 (199 unique) Heterodimer associations and dissociations 45
Complexes 63 State transitions 193
Genes 36 Transports 60
RNAs 63 (35 unique) Transcriptions and translations 41
Othera 54 Otherb 92
aSimple molecules, phenotype, degraded products, ions, drugs, unknown molecules
bKnown transition omitted, truncation, unknown transitions, unknown negative influence, positive influence
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modular view of the CCKR map similar to what has
been previously reported for the E2F-Retinoblastoma
signaling pathway [27, 68]. The resulting 18 modules
(Methods, Table 2, Fig. 4a, Additional file 2) are fully
based on the underlying detailed map and help to com-
prehend higher order map structure, navigate through
the map and work on functional modules. Each of the
modules represents a structural and functional signaling
subunit, combining a set of closely coordinated molecu-
lar events concerning a particular protein or a protein
complex (see e.g. the Rho GTPase module in Fig. 5a).
Furthermore, the regulatory relations (activating/repres-
sing) connecting the modules (Fig. 4a, black and redFig. 3 Degree distribution of the CCKR map proteinsarrows) are directly derived from the relations encoded
in the underlying detailed map (Fig. 2) and the modular
view thus represents central decision-making aspects of
CCKR signaling. Additional file 3 gives details for each
module including the complete list of components and a
discussion of their roles in the signaling mechanisms.
Gastrin-regulated cellular processes involve different sets
of signaling modules
Depending on cell type and the state of cells, gastrin can
induce different cellular outcomes, such as proliferation,
migration and apoptosis. In order to investigate what is
known about the involvement of each of the signaling
pathway modules in these processes, we checked the
Table 2 Overview of the 18 modules and the numbers of defining
(specific) components in each module
Module name # defining components
AKT1 14
AP1 2
ATF2 2
BCL 5
β-catenin 5
CCK1R 4
CCK2R 8
EGFR 3
FAK1/2 6
MAPK1/3 6
MAP3K11 8
NFκB 8
NOS1 8
PKA 10
PKC 12
RAF1 4
Rho GTPase 8
SRC 8
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map. We chose to focus on gastrin-mediated effects, be-
cause molecular mechanism studies of gastrin-regulated
cellular responses are more abundantly reported in lit-
erature. Specifically, we recorded all instances where ex-
perimental evidence was reported indicating that the
function of a specific signaling component had an effect
on the cellular outcome in response to gastrin treatment.
Based on this literature survey, involvement in cellular
outcomes was indicated in Fig. 4a. While central mod-
ules such as PKC, AKT1, Rho GTPase, MAP3K11,
MAPK1/3 and AP1 are reportedly involved in all three
cellular outcomes, other signaling mechanisms are more
specific in their effect, e.g. the BCL-module signaling is
only observed to be involved in apoptosis (Fig. 4a).
Below, we provide a brief description of signaling mod-
ules and components involved in each of the cellular
outcomes to gastrin treatment.
Proliferation
Molecular mechanisms underlying gastrin-mediated pro-
liferation involve regulation of protein synthesis and cell
cycle. Protein synthesis is stimulated via the AKT1-
module component mTOR triggering p70 S6 kinase [69,
70]. Gastrin-induced transcription of Cyclin D1, a cen-
tral regulator of cell cycle progression, is mediated by
JUN, FOS, CREB1, and TCF7L2 [71–75], which are
components of the modules: AP1, ATF2 and β-catenin.
The modular representation (Fig. 4a) shows that EGFR-associated signaling enhances gastrin-induced prolifera-
tion by feed-forward mechanisms involving SRC module
components. The modular map (Fig. 4a) shows that the
AKT1 module inhibits RAF1 and consequently MAPK1/
3-module pathways. The molecular mechanism for this
is AKT1 kinase-mediated phosphorylation of RAF1 [76].
The modular map thus allows us to hypothesize that the
activating role of AP1- and ATF2-submodule signaling
in proliferation is more likely to proceed via SRC-
MAP3K11 pathways, since these are not inhibited by
AKT1.
Migration
Gastrin promotes cell migration by activating transcrip-
tion of MMP7 and MMP9 [77, 78] via transcription fac-
tors SNAI1, β-catenin and JUN [63] represented in the
β-catenin- (SNAI1, β-catenin)- and AP1-(JUN) modules.
Cell adhesion, tightly linked to cell migration, is regu-
lated through components in the FAK1/2 module (FAK1
and FAK2; Paxillin, CAS, and CRK [79, 80]), which is
controlled via both PKC and SRC-modules. The module
representation (Fig. 4a) indicates that PKC- and SRC-
modules exert a positive feedback regulation on the
FAK1/2 module.
Anti-apoptosis
Apoptosis is inhibited by gastrin via several mechanisms
including BCL-mediated repression of pro-apoptotic
caspases and AP1-activated expression of Clusterin [64,
65, 81, 82]. The modular representation reveals that
these cellular responses are regulated both by PKC inde-
pendent and PKC dependent mechanisms. This applies
to NFκB and its downstream anti-apoptotic BIRC2 and
BIRC3 target genes, which can be activated either dir-
ectly by PKC or independently of PKC through the Rho
GTPase module. Likewise, the AKT1-involvement in
regulation of the BCL-module can be mediated by PKC-
dependent mechanisms or independently of PKC by the
CCK2R - Rho GTPase pathway. Activation of AP1, on
the other hand, seems to be strictly dependent on PKC
that mediates its effect via either RAF1-MAPK1/3 or
SRC-MAP3K11 cascades.
We note that the AKT1-module both inhibits the
RAF1-MAPK1/3-route to AP1-activation and enhances
Rho GTPase activation of the BCL-module. Thus, AKT1
can potentially promote BCL-module apoptosis-regulating
mechanisms and at the same time block MAPK1/3-medi-
ated AP1-activation. In the latter configuration the cell
would rely on MAP3K11 to bypass the inhibitory effect of
AKT1 on AP1-mediated regulation of gene expression.
Extending the CCKR map with PPI data
The comprehensive CCKR signaling map (Fig. 2) has
been constructed with a knowledge-driven approach
Fig. 4 CCKR modular map and PathExpand interactors. a The CCKR map modules are connected by ‘activation’ and ‘inhibition’ relationships (indicated by
black lines with a pointed arrow and red lines with a bar-headed arrow, respectively) and comprise i) receptor-centered modules CCK1R, CCK2R and EGFR,
ii) modules common to CCK1R and CCK2R (PKC, SRC, MAP3K11, MAPK1/3, RAF1, AKT1, NFκB, MAP3K11, Rho GTPase, FAK1/2), iii) CCK1R-specific modules
NOS1 and PKA, and iv) CCK2R-specific modules BCL and β-catenin. Color-coding depicts published experimentally documented information concerning
involvement of the module-encoded signaling mechanisms in gastrin-mediated regulation of cellular responses proliferation, migration and apoptosis.
b PathExpand interactors (full names, see Table 3) shown for seven of the 18 modules (excluding transcription factor- centered modules)
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well-documented by scientific evidence in the literature.
This thereby inevitably leaves significant gaps concerning
signaling events and mechanisms that have not yet been
studied and evidenced. We have therefore exploited large-
scale PPI data to assess how it can complement the CCKR
signaling map by a data-driven strategy.
We identified 4119 proteins interacting with at least
one CCKR signaling protein (Methods, Additional file
4). Among 199 unique proteins present in our CCKRsignal transduction map, 146 were part of this large
protein-protein interaction network. We then set out to
identify protein interactors that could be of high interest
as potential interactors or modulators of the complete
CCKR signaling map (Fig. 4a). For this, we analyzed each
of the 4119 proteins interacting with the CCKR map
proteins using the PathExpand approach [28]. PathExpand
checks each interactor to see if it satisfies a number of
topological criteria leading to increased compactness of
the complete CCKR map. We identified a total of 102
Fig. 5 Rho GTPase module and PathExpand interactors. a Complete Rho GTPase module including ‘Defining’ components (pink) i.e. specific
components within this module, as well as ‘Incoming’ (green) and ‘Outgoing’ (yellow) components representing upstream regulators and
downstream effectors respectively. All components shown are encoded in the detailed CCKR map (Fig. 2). b Rho GTPase module shown with
PathExpand interactors (colourless) (Additional file 5)
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them being components of the original CCKR map. The
70 PathExpand interactors not present in the original
CCKR map are listed in Table 3. Interestingly, the set of
70 new CCKR map candidates include 30 proteins that
are not known to participate in any signaling pathways
listed in the pathway databases KEGG, Reactome, PAN-
THER and Biocarta (Table 3). A GO term overrepresenta-
tion analysis [83] showed that the set of map candidates is
enriched in molecular functions relating to protein ki-
nases, protein phosphatases and GTPase-regulators, indi-
cating that many of them could potentially regulate the
CCKR pathway via phosphorylation-dephosphorylation
mechanisms and by interfering with small GTPase signal-
ing. Among these are the protein kinases STK4, CSK21,
CSK22, ITPKA, FLT4, DDR2, KS6KA4 and MAPK15 and
a high number of Dual specificity phosphatases (DUSP1,
2, 4, 5, 7, 9, 22) in addition to phosphatases PHLPP1 and
PTPRR.
Inspection of the expanded networks resulting from
the combination of PathExpand protein interactors with
7 CCKR modules (Fig. 4b, transcription factor centered
modules excluded) shows that 11 of the protein interac-
tors are linked to more than one CCKR module and can
contribute both to PKC-independent (e.g. ARHGEF25,
ARHGAP31, TBC1D3F) and PKC dependent (e.g. ICMT)
signaling routes. In contrast, 21 protein interactors arelinked to only one module, suggesting that they may act as
preferential regulators of this module. For instance, the
Mitogen activated kinase 15 (MAPK15) is a compactness
increasing protein only for the SRC module, where it in-
teracts with the two kinases SRC and CSK.
CCKR map and genome-scale PPI generate hypotheses
for refinement of Rho GTPase module mechanisms
By taking a closer look at the gastrin regulated Rho
GTPase module and its identified PPI extensions, we
here discuss putative novel signaling mechanisms in-
volved in gastrin-mediated regulation of the Rho GTPase
signaling.
Central to the Rho GTPase module (Fig. 5a) is the ac-
tivation of small GTPases, RHOA, RAC1, and CDC42
by guanine exchange factor proteins (GEFs), which trig-
ger conversion of the inactive GDP-bound form of small
GTPases to the active GTP-bound form. The GEFs in
gastrin-mediated Rho GTPase signaling are Leukemia-
associated Rho guanine-nucleotide exchange factor (LARG)
and the trimeric receptor-associated G-protein complexes
Gαq and Gα13. In addition, HRAS may also act to activate
RHOA and CDC42. The small GTPases RHOA, RAC1,
and CDC42 are documented to activate kinases ROCK1
and PAK1, which are both part of the gastrin-regulated
Rho GTPase module, and of kinase AKT1, part of the
gastrin-regulated AKT1 signaling module. The inactive
Table 3 List of PathExpand interactors
CCK model protein interactors Protein name Annotated in pathway databasesa
AFAP1 actin filament associated protein 1
AKAP14 A kinase (PRKA) anchor protein 14
ARHGAP31 Rho GTPase activating protein 31 Yes
ARHGEF25 Rho guanine nucleotide exchange factor (GEF) 25
ASXL1 additional sex combs like 1 (Drosophila)
ATP5J ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6 Yes
BLVRA biliverdin reductase A Yes
BNIP1 BCL2/adenovirus E1B 19 kDa interacting protein 1 Yes
CCDC88A coiled-coil domain containing 88A
CD59 CD59 molecule, complement regulatory protein Yes
CPS1 carbamoyl-phosphate synthase 1, mitochondrial Yes
DDR2 discoidin domain receptor tyrosine kinase 2
DUSP2 dual specificity phosphatase 2 Yes
DUSP22 dual specificity phosphatase 22 Yes
DUSP4 dual specificity phosphatase 4 Yes
DUSP5 dual specificity phosphatase 5 Yes
DUSP7 dual specificity phosphatase 7 Yes
DUSP9 dual specificity phosphatase 9 Yes
EIF4EBP2 eukaryotic translation initiation factor 4E binding protein 2
EIF4EBP3 eukaryotic translation initiation factor 4E binding protein 3
ERRFI1 ERBB receptor feedback inhibitor 1
FAM59A family with sequence similarity 59, member A
FCGR2C Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene) Yes
FKBP1A FK506 binding protein 1A, 12 kDa
FLT4 fms-related tyrosine kinase 4 Yes
GAB3 GRB2-associated binding protein 3 Yes
GJB1 gap junction protein, beta 1, 32 kDa Yes
GLTSCR1 glioma tumor suppressor candidate region gene 1
GNB1L guanine nucleotide binding protein (G protein), beta polypeptide 1-like
GUCY1A3 guanylate cyclase 1, soluble, alpha 3 Yes
ICMT isoprenylcysteine carboxyl methyltransferase
IQGAP2 IQ motif containing GTPase activating protein 2
IRF5 interferon regulatory factor 5 Yes
ITPKA inositol-trisphosphate 3-kinase A Yes
KIAA2026 KIAA2026
KSR1 kinase suppressor of ras 1
MAPK15 mitogen-activated protein kinase 15 Yes
MCF2L MCF.2 cell line derived transforming sequence-like Yes
MTPN myotrophin
MUC12 mucin 12, cell surface associated
NCF1B neutrophil cytosolic factor 1B pseudogene
NFATC3 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 Yes
NFKBIZ nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta
Tripathi et al. BMC Systems Biology  (2015) 9:40 Page 10 of 15
Table 3 List of PathExpand interactors (Continued)
OGN osteoglycin
OPHN1 oligophrenin 1 Yes
PARD6G par-6 partitioning defective 6 homolog gamma (C. elegans) Yes
PDCD11 programmed cell death 11
PDE3B phosphodiesterase 3B, cGMP-inhibited Yes
PEBP4 phosphatidylethanolamine-binding protein 4 Yes
PFKFB3 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 Yes
PHLPP1 PH domain and leucine rich repeat protein phosphatase 1 Yes
PI4K2B phosphatidylinositol 4-kinase type 2 beta
PIK3C2B phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta Yes
PLEKHG2 pleckstrin homology domain containing, family G (with RhoGef domain) member 2 Yes
PPP1R14A protein phosphatase 1, regulatory (inhibitor) subunit 14A Yes
PTPN7 protein tyrosine phosphatase, non-receptor type 7 Yes
PTPRR protein tyrosine phosphatase, receptor type, R Yes
RASGRP3 RAS guanyl releasing protein 3 (calcium and DAG-regulated) Yes
RET ret proto-oncogene Yes
RIPK4 receptor-interacting serine-threonine kinase 4
RPL27 ribosomal protein L27 Yes
RPS6KA4 ribosomal protein S6 kinase, 90 kDa, polypeptide 4 Yes
SEMG2 semenogelin II
SH2D3C SH2 domain containing 3C
SIT1 signaling threshold regulating transmembrane adaptor 1
TBC1D3F TBC1 domain family, member 3 F
TIAF1 TGFB1-induced anti-apoptotic factor 1
TNP1 transition protein 1 (during histone to protamine replacement)
TPX2 TPX2, microtubule-associated, homolog (Xenopus laevis) Yes
TRH thyrotropin-releasing hormone
aincludes KEGG, PANTHER, Biocarta and Reactome
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activating proteins (GAPs) that enhance hydrolyzation of
the bound GTP. In gastrin-mediated signaling deactivation
of RHOA and RAC1 is effectuated by GAPs, ARHGAP4
and RGS2, respectively.
Eight of the ten PathExpand protein interactors
(Fig. 5b, Additional file 5) of Rho GTPase module com-
ponents interact with one or more of the small GTPases
RHOA, RAC1, and CDC42. All of these protein interac-
tors are annotated with GO-terms indicating a known
role in regulation of small GTPases, and four of them
(IQGAP2, TBC1D3F, ARHGAP31, OPHN1) are known
as GTPase activators. We suggest that these eight pro-
teins are strong candidates for potentially novel modula-
tors of gastrin-mediated Rho GTPase module signaling.
Three of the proteins (TBC1D3F, ARHGAP25, and
ICMT) are not yet present in any of the common path-
way databases (see Table 3). The evidence presented
here, indicating that the three proteins have tightinteraction with multiple proteins involved in gastrin
signaling, demonstrates that our approach is well suited
to identify testable hypotheses, even for candidates for
which knowledge in public databases is still sparse.
The PathExpand interactor BNIP1 (BCL2/adenovirus
E1B 19 kDa interacting protein 1) interacts with two
downstream BCL module components BCL2L1 and BCL2,
both involved in effectuating the gastrin anti-apoptotic sig-
nal. Since BNIP1 is known to be involved in SNARE ves-
icular transport, our findings indicate that it may be an
interesting candidate to follow up with investigating a
potential role of vesicular transport in modulating BCL-
linked signaling mechanisms in the gastrin signaling path-
way. The PathExpand interactor programmed cell death 11
(PDCD11) interacting with the two subunits of NFκB tran-
scription factor (NFκB1 and TF65) is known to be involved
in maturation of ribosomal RNA but may also play a role
in mRNA processing. Our results identify PDCD11 as a
potential candidate to follow up in experimental analysis of
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regulation in cellular responses to gastrin.
Discussion
In the work presented here, we set out to build a com-
prehensive and well-annotated molecular interaction
map to aid future studies involving gastrin or CCK. A
mechanistic understanding of CCK1R and CCK2R signal-
ing networks is essential for experiment design and data
interpretation in biological systems involving gastrin- and
CCK-regulated processes. Moreover, it may enhance the
identification of therapeutic chemicals able to target dis-
ease, by using the map as a functional interaction diagram
with components that modeling indicates as prime targets
for perturbation, as described by Lee et al. [84], who suc-
cessful designed a drug-induced rewiring of the ‘state’ of
oncogenic signaling networks to maximize the susceptibil-
ity to anticancer drugs. The current map depicting mo-
lecular signaling mechanisms underlying CCK1R and
CCK2R triggered cellular responses may provide a tool to
guide further investigations into normo- and pathophysio-
logical processes such as gastrin-regulated stomach mu-
cosa homeostatis and gastrin-linked carcinogenesis [59,
64, 85, 86], and cholecystokinin-induced hypoplasia, cell
regeneration and digestive enzyme secretion [87] as well
as to identify potential intervention strategies for associ-
ated disease states.
Some pathway proteins and reactions of the CCKR
signaling map are also described in the Reactome [14]
and KEGG [15] databases. However, the CCKR map
constitutes a vastly more comprehensive and integrated
model, providing detailed signaling reactions linking the
receptors CCK1R and CCK2R all the way to regulated
genes and cellular responses. For comparison, the re-
cently published gastrin signaling map [26] comprises
approximately half of the molecules and only a quarter
of the reactions presented in our CCKR map. Similarly,
knowledge currently in Reactome covers less than 5 % of
the pathway details presented here. The CCKR map
therefore represents a significant increase in curated sig-
naling information. The provided SBML version of the
CCKR map can serve as a starting point to generate
quantitative mathematical models [88] for simulation
and prediction of cellular outcomes in response to per-
turbations of the network.
We enhance the applicability of the map for hypothesis
generation by two central strategies. First, we provide a
computationally modularized version of topologically and
functionally connected meta-nodes. This modular view
simplifies the complete CCKR map and provides for an
improved, higher level comprehension of pathway regula-
tory aspects concerning cell fate decisions related to pro-
liferation, migration and apoptosis. Secondly, we take
advantage of public large scale PPI knowledge to predictnew potential regulators of CCKR signaling, including 70
interactors that significantly enhance the compactness of
the CCKR map [28], through tight direct and indirect in-
teractions with map proteins. Although experimental
validations are needed to confirm these new CCKR sig-
naling mechanisms, they represent an important source
of high quality hypotheses that may be taken as a first
step to develop a better comprehension of CCKR path-
way functionality.
Compared to other recently published computational
approaches for high-throughput hypothesis generation
[20, 89, 90], the advantage of our strategy is the combin-
ation of i) biological background knowledge encoded in
the signaling map, including the modules, manually cu-
rated from literature reporting detailed experimental ana-
lyses of gastrin- and CCK-signaling, and ii) large-scale PPI
information downloaded from available databases of inter-
actions, filtered for binary physical interaction based on
selected experimental detection methods.
Conclusion
Our work demonstrates how publicly available tools
can aid in the manual curation of an extensive network
topology, in order to build a foundation for a systems
understanding of CCKR-mediated cellular responses.
Furthermore, the integration of a comprehensive model
of complex biological networks with genome scale data
can provide new knowledge and hypotheses on molecu-
lar mechanisms underlying cellular processes. Further
development of the resources presented here should be
of high interest in translational research aimed at iden-
tifying new targets and biomarkers for treatment and
diagnostics of gastrin- and/or cholecystokinin-related
disease, including cancer.
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